CELESTICA INC (CLS)       12.37  -0.07 (-0.56%)

12.37  -0.07 (-0.56%)

CA15101Q1081 - Common Stock - After market: 12.37 0 (0%)

Buy % Consensus

Analysts have set a mean price target of 11.35. This target is -8.29% below the current price.
CLS was analyzed by 8 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about CLS.
In the previous month the buy percentage consensus was at a similar level.
CLS was analyzed by 8 analysts. More opinions would make the average more meaningful.

Price Target

Price Low Median Mean High 12.3710.4011.4411.3512.35 - -15.94% -7.53% -8.29% -0.13%

Up and Down Grades

Date Firm Action Rating
2023-02-23 RBC Capital Reiterate Sector Perform
2023-01-27 BMO Capital Maintains Outperform
2023-01-27 Citigroup Maintains Neutral
2022-10-26 RBC Capital Maintains Sector Perform
2022-10-26 Citigroup Maintains Neutral
2022-08-18 Argus Research Upgrade Hold -> Buy
2022-07-27 BMO Capital Upgrade Market Perform -> Outperform
2022-07-27 Citigroup Upgrade Sell -> Neutral
2021-09-23 RBC Capital Maintains Sector Perform
2021-07-29 TD Securities Upgrade Hold
2021-07-28 RBC Capital Upgrade Sector Perform
2021-07-28 TD Securities Upgrade Hold
2021-06-04 RBC Capital Maintains Sector Perform
2021-04-30 RBC Capital Initiate Sector Perform

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA